ADIPOQ and melanoma: Its mutations are likely involved in migration, invasion, and tumorigenicity of melanoma cells [52], and together with CLDN7 it has been associated to the modification of adiponectin response to lifestyle intervention in overweight/obese diabetic individuals [53].